The Medicines Control Agency (MCA) has withdrawn licenses for prescription evening primrose drug products under the brand names of Epogam and Efamast. This was because there is not enough evidence that they are effective.
The Medicines Control Agency (MCA) has withdrawn licenses for prescription evening primrose drug products under the brand names of Epogam and Efamast. This was because there is not enough evidence that they are effective.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023